Skip to main content
ICLR
NASDAQ Industrial Applications And Services

ICON PLC Files Restated Annual Report, Discloses Material Weaknesses and $465M Impairment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$118.45
Mkt Cap
$9.045B
52W Low
$66.57
52W High
$211
52W Position info
78% above low
Off High info
44% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ICLR sits 78% above its 52-week low of $66.57.

Summary

ICON PLC's annual report details a major financial restatement, internal control failures, and a large asset impairment, highlighting severe financial reporting issues and ongoing legal challenges.


Key Events · Corporate Governance and Compliance · ICLR

  • Financial Restatement

    Restated 2023 and 2024 financials due to improper revenue adjustments and accounting errors, reducing 2024 net income by $52.3 million (6.6%) and 2023 net income by $58.1 million (9.5%).

  • Material Weaknesses in Internal Controls

    Management concluded internal controls over financial reporting and disclosure controls were ineffective as of December 31, 2025, due to identified material weaknesses.

  • Significant Asset Impairment

    Recorded a $364.2 million goodwill impairment and $101.0 million non-financial asset impairment in 2025 for its Data Solutions reporting unit.

  • Compliance and Debt Waivers

    The filing of this delayed 2025 annual report addresses a Nasdaq non-compliance notice. The company also secured waivers from lenders for late financial statement delivery, preventing a technical default.


Analysis · ICLR · Industrial Applications And Services

ICON PLC has filed its delayed 2025 annual report, revealing a significant restatement of financial statements for 2023 and 2024 due to improper revenue adjustments and accounting errors. The company also disclosed material weaknesses in its internal controls over financial reporting and recorded a substantial $465.2 million goodwill and non-financial asset impairment. These issues led to a Nasdaq non-compliance notice, which the company addressed by securing waivers from lenders for late financial statement delivery.

How filings like this one have moved

In the 30 days to Aug 26, 2026, 43.5% of the 1024 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ICLR was trading at $118.45 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9B. The 52-week trading range was $66.57 to $211.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ICLR - Latest Insights

ICLR
Aug 06, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $163.55
Real-time Price: $168.91 info
Change: +$5.36 (+3%) info
Market Cap: $13.032B info
ICLR
Aug 04, 2026, 8:39 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.00
Real-time Price: $168.91 info
Change: +$11.91 (+8%) info
Market Cap: $13.032B info
ICLR
Jul 30, 2026, 9:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $182.00
Real-time Price: $168.91 info
Change: -$13.09 (-7%) info
Market Cap: $13.032B info
ICLR
Jul 29, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $178.18
Real-time Price: $168.91 info
Change: -$9.27 (-5%) info
Market Cap: $13.032B info
ICLR
Jul 29, 2026, 4:22 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $185.00
Real-time Price: $168.91 info
Change: -$16.09 (-9%) info
Market Cap: $13.032B info